文献速递青光眼

高密度脂蛋白3胆固醇与原发性开角型青光眼:代谢组学与孟德尔随机化分析

High-Density Lipoprotein 3 Cholesterol and Primary Open-Angle Glaucoma: Metabolomics and Mendelian Randomization Analyses.
PubMed 文献 · Ophthalmology · 2021-09-28

在新加坡眼病流行病学研究基线8503人中,采用核磁共振代谢组学定量130种血脂相关代谢物,发现总HDL3胆固醇与原发性开角型青光眼(POAG)呈负相关,且孟德尔随机化分析提示可能为因果保护因素,而常规血脂指标无此关联。

要点

  • 总HDL3胆固醇每增加1个标准差,POAG风险降低(OR 0.72,95%CI 0.61-0.84)。
  • 孟德尔随机化显示HDL3胆固醇升高与POAG风险降低相关(OR 0.91,95%CI 0.84-0.99,P=0.021)。
  • 常规总胆固醇、HDL胆固醇、LDL胆固醇与POAG无显著关联。

核心结论

  • HDL3胆固醇与POAG的关系可能是因果性的且具有特异性。
  • 胆固醇转运失调可能参与POAG的发病机制。

研究设计与样本

  • 横断面研究,纳入新加坡眼病流行病学研究基线8503人。
  • 采用核磁共振代谢组学平台定量130种血脂相关代谢物。
  • 分析分两阶段:回归分析与贝叶斯网络建模,以及两样本孟德尔随机化分析。

主要发现

  • 175人(2.1%)患有POAG。
  • 逻辑回归显示总HDL3胆固醇(负向)和极大HDL中的磷脂(正向)与POAG相关。
  • 贝叶斯网络分析显示仅总HDL3胆固醇与POAG直接相关(OR 0.72,95%CI 0.61-0.84),独立于年龄、性别、眼压、BMI、教育水平、收缩压、眼轴长度和他汀类药物使用。
  • 孟德尔随机化使用GWAS识别的5个工具变量,逆方差加权法显示HDL3胆固醇升高与POAG风险降低相关(OR 0.91,95%CI 0.84-0.99,P=0.021)。
  • 其他MR方法(加权中位数、基于众数的估计、污染混合法)得到一致的OR估计。

关键数值与推荐

  • 总HDL3胆固醇每增加1个标准差,POAG的OR为0.72(95%CI 0.61-0.84)。
  • 孟德尔随机化中HDL3胆固醇对POAG的OR为0.91(95%CI 0.84-0.99,P=0.021)。

临床怎么用

  • HDL3胆固醇可能作为POAG风险评估的潜在生物标志物。
  • 针对胆固醇转运通路的干预可能为POAG防治提供新方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We hypothesized that the effect of blood lipid-related metabolites on primary open-angle glaucoma (POAG) would differ according to specific lipoprotein particles and lipid sub-fractions. We investigated the associations of blood levels of lipoprotein particles and lipid sub-fractions with POAG. DESIGN: Cross-sectional study. PARTICIPANTS: Individuals recruited for the baseline visit of the population-based Singapore Epidemiology of Eye Disease study (n = 8503). METHODS: All participants underwent detailed standardized ocular and systemic examinations. A total of 130 blood lipid-related metabolites were quantified using a nuclear magnetic resonance metabolomics platform. The analyses were conducted in 2 stages. First, we investigated whether and which lipid-related metabolites were directly associated with POAG using regression analyses followed by Bayesian network modeling. Second, we investigated if any causal relationship exists between the identified lipid-related metabolites, if any, and POAG using 2-sample Mendelian randomization (MR) analysis. We performed genome-wide association studies (GWAS) on high-density lipoprotein (HDL) 3 cholesterol (after inverse normal transformation) and used the top variants associated with HLD3 cholesterol as instrumental variables (IVs) in the MR analysis. MAIN OUTCOME MEASURE: Primary open-angle glaucoma. RESULTS: Of the participants, 175 (2.1%) had POAG. First, a logistic regression model showed that total HDL3 cholesterol (negatively) and phospholipids in very large HDL (positively) were associated with POAG. Further analyses using a Bayesian network analysis showed that only total HDL3 cholesterol was directly associated with POAG (odds ratio [OR], 0.72 per 1 standard deviation increase in HDL3 cholesterol; 95% confidence interval [CI], 0.61-0.84), independently of age, gender, intraocular pressure (IOP), body mass index (BMI), education level, systolic blood pressure, axial length, and statin medication. Using 5 IVs identified from the GWAS and with the inverse variance weighted MR method, we found that higher levels of HDL3 cholesterol were associated with a decreased odds of POAG (OR, 0.91; 95% CI, 0.84-0.99, P = 0.021). Other MR methods, including weighted median, mode-based estimator, and contamination mixture methods, derived consistent OR estimates. None of the routine lipids (blood total, HDL, or low-density lipoprotein [LDL] cholesterol) were associated with POAG. CONCLUSIONS: Overall, these results suggest that the relationship between HDL3 cholesterol and POAG might be causal and specific, and that dysregulation of cholesterol transport may play a role in the pathogenesis of POAG.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Nusinovici S, Li H, Thakur S, et al. High-Density Lipoprotein 3 Cholesterol and Primary Open-Angle Glaucoma: Metabolomics and Mendelian Randomization Analyses. Ophthalmology. 2021. PMID: 34592243. doi:10.1016/j.ophtha.2021.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。